Showing 16,961 - 16,980 results of 104,954 for search '(( i wt decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.56s Refine Results
  1. 16961
  2. 16962
  3. 16963
  4. 16964
  5. 16965
  6. 16966

    Comparison of potential energy minimization curves of hypothetical monomer chains from non-capsid and capsid dimers. by Weimin Wu (505435)

    Published 2020
    “…<p>Compared are apo 3KXS (A) and liganded 5E0I (B) non-capsid chains with the apo T = 4 1QGT capsid chains (C). …”
  7. 16967
  8. 16968
  9. 16969
  10. 16970

    Assessment of antioxidative capacity and ROS in HK-2 cells following molybdenum treatment and H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. by Joo Hong Joun (19287602)

    Published 2024
    “…(B) Oxidative stress was induced in HK-2 cells with 200 μM H<sub>2</sub>O<sub>2</sub>, and molybdenum was administered at 1, 2, 5, and 10 μg/mL. Molybdenum treatment significantly decreased cellular ROS at all doses (n = 5 per group). …”
  11. 16971

    CCR6 expression reduces mouse survival upon malarial challenge with Plasmodium berghei NK65 strain by Eduardo Lani Volpe da Silveira (12891589)

    Published 2022
    “…FINDINGS Although the sporozoite challenges yielded similar liver parasitic cDNA and parasitemia, KO mice presented a prolonged survival than WT mice. After iRBC challenges, KO mice kept displaying higher survival rates as well as a decreased IL-12 p70 concentration in the serum than WT mice. …”
  12. 16972

    Supplementary Material for: Structural and functional effects of C5aR1 antagonism in a rat model of neonatal hypoxic-ischemic encephalopathy by Saadat A. (18613231)

    Published 2024
    “…Reasoning C5aR1 antagonism can decrease excessive neuroinflammation and thereby improve neurological and functional outcomes, we tested this hypothesis in a rat model of HIE with PMX205, a small molecule that inhibits C5a-C5aR1 interaction. …”
  13. 16973

    Zebrafish homozygous for a frame-shift-inducing mutation in <i>tfap2e</i> do not display a pigmentation phenotype, and melanophores in <i>tfap2a/tfap2e</i> double mutants are melan... by Colin Kenny (8830949)

    Published 2022
    “…(<b>B</b>) PCR using primers in <i>tfap2e</i> exon 2 and intron 2 (e2-i2) amplifies a band of the expected 450 base pair size in <i>tfap2e</i> mutants but not wildtype (WT), whereas primers in exon 2 and exon 3 (e2-e3) amplify only in wild type. …”
  14. 16974
  15. 16975
  16. 16976

    Quantitative Multi-Parametric Magnetic Resonance Imaging of Tumor Response to Photodynamic Therapy by Tom J. L. Schreurs (3335379)

    Published 2016
    “…Tumor relaxation time constants (T<sub>1</sub> and T<sub>2</sub>) and apparent diffusion coefficient (ADC) were quantified at each time point. …”
  17. 16977

    Clathrin Assembly Protein CALM Plays a Critical Role in KIT Signaling by Regulating Its Cellular Transport from Early to Late Endosomes in Hematopoietic Cells by Shinya Rai (332061)

    Published 2014
    “…We here show that the number of Linage<sup>−</sup>Sca-1<sup>+</sup>KIT<sup>+</sup> (LSK) cells decreased in the fetal liver of <i>CALM</i><sup>−/−</sup> mice. …”
  18. 16978

    Table_1_Sub-Acute Treatment of Curcumin Derivative J147 Ameliorates Depression-Like Behavior Through 5-HT1A-Mediated cAMP Signaling.DOCX by Jianxin Li (158332)

    Published 2020
    “…Background<p>Major depressive disorder (MDD) is a severe mental disorder related to the deficiency of monoamine neurotransmitters, particularly to abnormalities of 5-HT (5-hydroxytryptamine, serotonin) and its receptors. …”
  19. 16979

    Effect of T0070907, PPARγ-antagonist (10 μM) on coronary reactive hyperemia (CRH) in wild type (WT) mice. by Ahmad Hanif (3094800)

    Published 2016
    “…Repayment/debt ratio (C) had a decreasing trend, but was not significant (p > 0.05). * p < 0.05 versus WT. …”
  20. 16980

    PowerPoint Slides for: Cognitive Impairment in Advanced Chronic Kidney Disease: The Canadian Frailty Observation and Interventions Trial by Foster R. (3291450)

    Published 2016
    “…Cognitive impairment was defined as a MoCA score of ≤24. We determined the prevalence and risk factors for cognitive impairment in patients with CKD stages G4-G5, not on dialysis. …”